IVF denied as experimental or investigational by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied IVF as Experimental — and How to Appeal

When UnitedHealthcare (UHC) classifies an IVF-related service as experimental or investigational, it means the plan's medical technology assessment determined that the service — whether IVF broadly, a specific laboratory technique, an adjunctive add-on, or a component medication — does not meet UHC's evidence standard for coverage. UHC maintains its own clinical policies, which are updated periodically and may lag behind evolving clinical practice. This classification is a coverage determination, not a clinical opinion, and it is challengeable on appeal.

## Why This Denial Is Appealable

IVF has been performed for decades and is endorsed as standard of care by the major reproductive medicine professional societies for appropriate indications. If UHC has classified IVF itself as experimental, this is inconsistent with the established medical consensus and is a strong basis for appeal. If the denial targets a specific adjunct or component, your physician can address whether that component is integral to standard-of-care treatment for your diagnosis or can be distinguished from the core procedure. Independent external reviewers — who are not employed by UHC — regularly overturn experimental designations when the clinical evidence is well-presented.

## Federal Appeal Framework

Under ACA §2719 and ERISA §503:

• Internal appeal: File within the window on your denial notice. Attach peer-reviewed literature, professional society guidelines, and a prescriber letter to the appeal.
• External review: After UHC upholds the denial, you generally have four months to request independent external review. This is one of the most powerful tools for overturning experimental designations, as the external reviewer applies objective clinical criteria.
• Expedited review: Request this when delay would significantly harm your health outcome or when your treatment window is time-sensitive.

## Concrete Appeal Steps

1. Request the denial letter and the specific UHC clinical policy used to classify the service as experimental. 2. Obtain UHC's published clinical policy for the denied service — available on UHC's provider portal — and read the evidence-review criteria carefully. 3. Ask your reproductive endocrinologist to write a letter that addresses each criterion in UHC's policy, citing professional society guidelines and peer-reviewed literature supporting the clinical use for your specific diagnosis. 4. Attach relevant professional society position statements and peer-reviewed systematic reviews as labeled exhibits. 5. If your state has an infertility coverage mandate, confirm whether it limits UHC's ability to deny IVF as experimental for covered indications.

## Documentation Checklist

• Denial letter and the UHC clinical policy cited
• Prescriber letter addressing each policy criterion
• Professional society guideline references for your specific diagnosis
• Peer-reviewed literature (systematic reviews and clinical practice guideline papers preferred)
• Diagnosis documentation and clinical chart notes
• State mandate language if applicable to your plan type

## Criteria-Mapping Strategy

Obtain UHC's clinical policy definition of experimental or investigational. Map each element of that definition against the evidence your physician provides. If UHC's policy permits coverage when peer-reviewed literature in indexed journals supports the use, identify and attach the specific publications. Addressing every element of the policy definition — rather than making a general argument — is the most effective approach for overturning experimental-designation denials at UHC.